Home -> Law Blog Directory -> Patent Law Blogs -> Patent Docs

Patent Law

: Patent Docs

Biotech/Pharma Lobbying Scoreboard - Third Quarter Update; BIO Lobbies for Biotech "Bailout"

By Donald Zuhn, Kevin Noonan, Chris Singer, Sherri Oslick, and Jason Derry

By Donald Zuhn --Patent Docs periodically reports on the lobbying efforts of various players in the biotech/pharma industry (see links below for reports on first and second quarter lobbying this year). Our interest in the lobbying expenditures of these companies and organizations stems from the push by Congress over the past two years to pass patent reform and follow-on biologics legislation. With both houses of Congress expected to renew their efforts to pass patent reform and follow-on biologics bills in 2009, we provide the following update on third quarter biotech/pharma lobbying activities: ? Amgen Inc. spent $2.4 million on third...img src="http://feeds.feedburner.com/~r/PatentDocs/~4/490312067" height="1" width="1"/

Full post as published by Patent Docs on December 19, 2008 (boomark / email).